PD Adequacy and Ultrafiltration

PD Adequacy and Ultrafiltration

Quick Answer: Adequate peritoneal dialysis is defined by a weekly Kt/V ≥1.7 (urea clearance metric adjusted for continuous therapy). Ultrafiltration depends on osmotic gradients from dextrose or icodextrin, dwell time, and peritoneal membrane transport properties classified by the peritoneal equilibrium test (PET). Ultrafiltration failure and high transport status are frequent CDN troubleshooting scenarios.

PD Adequacy: Kt/V and Clearance Targets

While hemodialysis adequacy often uses single-pool Kt/V per session and URR, PD clearance is continuous across the week. The CDN-aligned target for adequate PD is weekly Kt/V ≥1.7. This threshold accounts for the lower peak clearance but sustained 24-hour exposure compared with thrice-weekly hemodialysis (where spKt/V targets differ).

Total weekly clearance combines peritoneal Kt/V and residual renal Kt/V from any remaining urine output. As residual function declines—accelerated by peritonitis, nephrotoxic drugs, hypotension, and dehydration—prescriptions must intensify (more exchanges, higher fill volumes, or APD with additional cycles) to maintain adequacy.

Nurses monitor:

• 24-hour urine volume and residual urea clearance when ordered
• Total drain volumes and ultrafiltration trends
• Serum urea, creatinine, potassium, phosphorus
• Nutritional status (adequate protein intake supports outcomes)

Ultrafiltration: Osmotic Gradients and Solution Strengths

Ultrafiltration removes excess fluid when dialysate osmolality exceeds plasma osmolality. Standard solutions use dextrose at 1.5%, 2.5%, and 4.25%—with 4.25% providing the steepest gradient and greatest fluid removal (often called hypertonic in clinical shorthand). Nurses teach patients to match bag strength to daily weight trends: rising weight or edema may require a higher dextrose exchange; overuse of 4.25% accelerates membrane glucose exposure.

Icodextrin is a glucose polymer osmotic agent used for long dwells (8–16 hours). It sustains ultrafiltration without adding free glucose, making it valuable when dextrose-based long dwells under-remove fluid. CDN questions may ask for the osmotic agent in icodextrin solution—answer glucose polymer, not standard dextrose.

Lactate-buffered solutions have acidic storage pH (5.0–5.5), which can cause infusion discomfort. Bicarbonate-buffered solutions (pH ~7.0–7.4) improve biocompatibility and may reduce infusion discomfort—a comparison point when patients report exchange discomfort despite correct technique.

Peritoneal Equilibrium Test (PET)

The PET classifies membrane transport status using a standard 4-hour dwell with 2.5% dextrose. Creatinine dialysate-to-plasma (D/P) ratio at 4 hours places patients into high, high-average, low-average, or low transport categories.

• High transporters equilibrate solutes quickly—good short-dwell clearance but rapid glucose absorption causes early loss of osmotic gradient and poor ultrafiltration on short dwells. They may benefit from shorter dwells with more exchanges or icodextrin for long dwells.
• Low transporters equilibrate slowly—need longer dwells for adequate clearance; short APD cycles may under-deliver solute removal.

A low PET transport rate indicates slow solute transport and may correlate with difficulty achieving ultrafiltration on abbreviated dwells—do not confuse "low transport" with "good ultrafiltration"; these patients need time, not speed.

Worked Scenario: High Transport and Fluid Overload

A patient on APD reports rising weights despite prescribed cycles. PET previously showed high transport. Effluent from short overnight cycles shows minimal ultrafiltration. The nurse recognizes rapid glucose absorption depleted the osmotic gradient. The team may add icodextrin for the long dwell, adjust cycle timing, or limit dextrose-only long dwells—documenting trends for the nephrologist.

Ultrafiltration Failure

Ultrafiltration failure occurs when the membrane loses osmotic conductance—often from increased transcellular water in the peritoneal barrier or fibrosis after years of PD. Patients retain fluid despite appropriate dextrose prescriptions. Management includes sodium restriction, icodextrin long dwells, evaluation for encapsulating peritoneal sclerosis in chronic cases, and possible transition to hemodialysis when fluid control is unsafe.

Nursing Documentation and Prescription Adjustment

Adequacy and UF data drive prescription changes. Nurses ensure patients record:

1. Drain volume per exchange (compare to fill volume)
2. Daily weight at the same time
3. Blood pressure (hypotension worsens residual renal function)
4. Effluent appearance (cloudy effluent invalidates adequacy sampling until infection ruled out)

When weekly Kt/V falls below target, the interdisciplinary team may increase fill volume, exchange number, or switch CAPD to APD for additional cycles—nurses explain rationale so patients understand nonadherence is not the only cause of declining numbers.

Serum albumin and normalized protein catabolic rate (nPCR) supplement Kt/V when evaluating whether inadequate dialysis versus malnutrition is driving uremic symptoms—both can appear on integrated CDN vignettes.

CDN Exam Traps

1. Weekly Kt/V target for PD: ≥1.7, not the hemodialysis session Kt/V values.
2. PET dwell: Standard 4-hour dwell with 2.5% dextrose.
3. High transport: Rapid glucose uptake → poor UF on short dwells; icodextrin may help long dwells.
4. Icodextrin osmotic agent: Glucose polymer, not standard dextrose.
5. UF failure: Membrane conductance loss—not fixed by simply adding another manual exchange without assessing transport status.

PD adequacy and ultrafiltration are inseparable on the CDN exam—clearance targets mean little if fluid overload persists from failed osmotic removal.